🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a pilot, explorative, study to test the feasibility and safety of s...
Status
Withdrawn
Location
Unit of Oncology - Ospedali Riuniti of Bergamo
Start Date
2010-11
Trial ID
NCT01275612
Treatments Being Tested
The purpose of this study is to measure the effect of ticagrelor on the pha...
Status
Completed
Location
Research Site
Start Date
2024-08-05
Trial ID
NCT06554821
Treatments Being Tested
The study is being conducted to evaluate the efficacy, and safety of HR1803...
Status
Completed
Location
The Second Affiliated Hospital of Anhui Medical University
Start Date
2022-06-13
Trial ID
NCT05376904
Treatments Being Tested
The purpose of this study is to evaluate the effect of JTT-654 on diabetes ...
Status
Terminated
Location
Multiple Locations
Start Date
2009-09
Trial ID
NCT00997152
Treatments Being Tested
This study will be conducted to evaluate the efficacy of lecanemab in parti...
Status
Active Not Recruiting
Location
Banner Alzheimer's Institute- Clinical Trials Department
Start Date
2019-03-27
Trial ID
NCT03887455
Treatments Being Tested
The purpose of this study is to generate safety, reactogenicity (assessment...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-08-05
Trial ID
NCT04026009
SPH3127 tablet is a of renin inhibitor. It is expected to be a new drug for...
Status
Completed
Location
Beijing Anzhen Hospital, Capital Medical University
Start Date
2019-01-11
Trial ID
NCT03756103
Treatments Being Tested
The purpose of this Phase III study is to evaluate the efficacy and safety ...
Status
Completed
Location
Research Site
Start Date
2022-01-03
Trial ID
NCT05166889
Treatments Being Tested
The purpose of the study is to learn about the safety of MK-2225, including...
Status
Completed
Location
Clinical Pharmacology of Miami (Site 0002)
Start Date
2023-11-21
Trial ID
NCT06643390
This is a Phase 1, open-label, parallel-group study in subjects with varyin...
Status
Completed
Location
Orlando Clinical Research Center
Start Date
2021-01-12
Trial ID
NCT05470725
Treatments Being Tested